August 3, 2026
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) - Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former president and chief operating officer of Verisk Analytics, a strategic data analytics and technology partner to the global insurance industry. He will serve on the board’s Audit & Compensation committees. “Mark’s leadership across the global insurance and analytics sectors, along with his experience guiding public companies through growth and transformation, makes him an outstanding addition to the Board," said Kenneth H. Paulus, non-executive Chairman of the Teladoc Health board. "His perspective on how data, technology and AI are reshaping complex industries will be invaluable as Teladoc Health evolves." Mr. Anquillare has more than 30 years of financial and executive leadership experience. He served as Verisk’s chief financial officer beginning in 2007, leading the...
Read More
July 29, 2026
Teladoc Health Reports Second Quarter 2026 Results
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2025 (“Second Quarter 2025”). Highlights Second Quarter 2026 revenue of $606.9 million, down 4% year-over-year Second Quarter 2026 net loss of $38.9 million, or $0.21 per share Second Quarter 2026 adjusted EBITDA of $65.7 million, down 5% year-over-year Integrated Care segment revenue of $394.3 million, up 1% year-over-year, and adjusted EBITDA margin of 16.5% BetterHelp segment revenue of $212.6 million, down 12% year-over-year, and adjusted EBITDA margin of 0.2%
“We continue to make progress on the priorities we believe are most important to the long-term success of Teladoc Health. Our second-quarter results were within our guidance ranges on a consolidated basis and...
Read More